Dermapharm Holding SE
OTC:DMPHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dermapharm Holding SE
OTC:DMPHF
|
DE |
|
Evolv Technologies Holdings Inc
NASDAQ:EVLV
|
US |
|
A
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMIRT
|
TH |
|
E
|
E ON SE
XMUN:EOAN
|
DE |
|
I
|
IDNTT SA
MIL:IDNTT
|
CH |
|
Bucher Industries AG
LSE:0QQN
|
CH |
|
DWS Group GmbH & Co KgaA
F:DWS
|
DE |
|
T
|
Tecnicas Reunidas SA
MAD:TRE
|
ES |
|
B
|
Bowim SA
WSE:BOW
|
PL |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
US |
Wall St Price Targets
DMPHF Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMPHF is 60.35 USD with a low forecast of 52.59 USD and a high forecast of 74.55 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMPHF's stock price target?
Price Target
60.35
USD
According to Wall Street analysts, the average 1-year price target for DMPHF is 60.35 USD with a low forecast of 52.59 USD and a high forecast of 74.55 USD.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 8%.
